for Multi-Billion Dollar Healthcare Wearables Market”
AI/ML Innovations (OTC: AIMLF), a featured presenter at Wall Street Reporter's "Next Super Stock"
investor conference series, recently updated investors on growth initiatives at AIMLF’s portfolio of
digital health businesses including HealthGauge, a wearable personal health monitoring & management system,
using Artificial Intelligence and Machine Learning, and Tech2Heal a European mental health app innovator.
Of significant interest for investors is AIMLF’s landmark patent position for wearable health monitors -
which could position AIMLF to collect licensing fees and royalties on the $13.8 Billion global
Smart Wearable Healthcare Devices (projected to reach $37.4 Billion by 2028.
Source: Verified Market Research.) AIMLF is now starting to license its technologies to health wearables companies,
and collecting royalties.
With typical royalties of 2% of gross sales,
AIMLF could potentially generate significant recurring revenues from companies infringing on
its broad patent position in the nearly $14 billion health wearables market.
Watch AI/ML Innovations (OTC: AIMLF) (CSE: AIML) NEXT SUPER STOCK Video:
https://www.wallstreetreporter.com/2022/05/31/next-super-stock-ai-ml-billion-dollar-patent/4
Consumer Automotive Finance, Inc. Announces Cancellation of 200 Million Common Shares and Updates on Name and Ticker Symbol Change • CAFI • Dec 6, 2024 12:45 PM
4Cable TV International, Inc. (OTC.PK: CATV) Signs Letter of Intent to Acquire MariJ Pharmaceuticals from Branded Legacy, Inc. and Retains New Counsel for Name Change with FINRA • CATV • Dec 6, 2024 8:00 AM
Bantec's Howco Distributing Co. and Bantec Environmental Corp. Win Contracts • BANT • Dec 5, 2024 10:00 AM
Kona Gold Beverage, Inc. Announces Strategic Reorganization and a Bold New Direction • KGKG • Dec 5, 2024 9:33 AM
Branded Legacy, Inc. Strengthens Biotech Leadership, Focuses on Expansion, and Advances Strategic Rebranding • BLEG • Dec 5, 2024 8:30 AM
Avant Technologies' Partner, Ainnova, Signs Pilot Program with Roche to Combat Diabetic Retinopathy • AVAI • Dec 4, 2024 8:00 AM